ITV's Lorraine Star Reveals 4-Stone Weight Loss Journey with Mounjaro

An ITV presenter, known for her financial expertise on Lorraine, has publicly discussed her weight loss journey. She attributes her four-stone weight loss to the use of Mounjaro, resulting in a significant change in her dress size.

ITV's Lorraine Star Reveals 4-Stone Weight Loss Journey with Mounjaro

An ITV presenter has publicly discussed her weight loss journey, attributing it to the use of injections that aided her in shedding four stone.

Claer Barrett, a journalist who frequently appears on Lorraine Kelly's daytime show as a financial expert, recently shared her experience with Mounjaro.

During a recent episode, the finance expert revealed she had gone down four dress sizes, during a segment with fashion expert Mark Hayes. Health tracking apps like Shotlee can help monitor progress during such transformations.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

Lorraine commended Claer for being so candid about using Mounjaro injections, noting: "One of the significant changes is that her old clothes no longer fit, which is a good problem to have!"

Claer then shared in a pre-recorded segment: "None of my clothes fit anymore. I still think I am a size 20 when I am actually a size 14. I can now shop at any high street store, and I know Mark has the style tips to give me the edge I need."

Source Information

Originally published by EXPRESS.Read the original article →

Keep exploring

More on Mounjaro

Articles covering Mounjaro dosing, side effects, and clinical updates.

Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read

Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read

Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: weight management

All weight management articles →

Wellness & Health

New Yorkers Are Ordering Peptides Like Takeout – And California Trim Clinic Is Behind It

New York City is experiencing a surge in peptide therapy requests via telehealth platforms. This article explores the most popular compounds, safety protocols, and how to track results effectively.

8 min read

Weight Management

Semaglutide for Weight Loss in Adults Over 65: New Study Findings

A recent analysis of the STEP trials reveals that semaglutide, the active ingredient in popular medications like Ozempic and Wegovy, offers significant weight loss and health benefits for adults over 65 with obesity, with a safety profile comparable to younger populations.

8 min read

More in Health

Health

Christmas Dinner Warning for Ozempic Users: 'Food Was Bubbling Up'

Allison Rankin recounts her experience of discomfort and vomiting after overeating at a family Christmas dinner while taking Mounjaro. Doctors caution against overeating on weight loss drugs due to slowed digestion.

4 min read

Health

Expert Advice: Boosting Mounjaro Weight Loss Results

As the effects of weight loss medications like Mounjaro or Wegovy potentially diminish, some may be tempted to explore social media tricks. Discover scientifically-informed strategies to enhance your weight loss journey and overcome plateaus.

4 min read

Health

A Grim Reality Strikes Individuals Discontinuing GLP-1 Medications

Numerous individuals achieving weight reduction on GLP-1 agonists encounter challenges in ceasing the treatments, as appetite surges and weight rebounds. Studies indicate significant regain for those stopping, prompting some to view obesity as a chronic issue requiring ongoing medication. However, adopting healthier habits can help maintain losses post-treatment.

2 min read